Clinical Core
Clinical Core
批准号:
10200784
负责人:
LISA Allyn BOARDMAN
金额:
$25.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2024-06-30
关键词:
AnatomyAreaBile fluidBiological Specimen BanksCell SeparationClinicClinicalCollectionComputer softwareConsentCore FacilityDNADataDevelopmentDigestive System DisordersDiseaseDiverticulitisEndoscopic Surgical ProceduresEndoscopyEnteralEquipment and supply inventoriesFecesFeedbackFreezingFresh TissueFrozen SectionsFundingGastroenterologyGrantHealth Services AccessibilityHepatologyHumanHuman MicrobiomeHuman ResourcesIndividualInflammationInfrastructureInstitutional Review BoardsLaboratoriesLiverLiver diseasesMesenteryMicrofluidicsMovementNeurosciencesOnline SystemsOperative Surgical ProceduresOrganoidsPathologyPatientsPlasmaPrimary Cell CulturesProceduresProcessProteomicsProtocols documentationPublicationsQuestionnairesResearchResearch PersonnelResearch Project GrantsResourcesScientistSerumServicesSignal TransductionSoftware ToolsSourceStandardizationSurveysTechnologyTissue BanksTissuesTranslatingTranslational Researchbasebiobankc newcell transformationcost effectivehuman tissuemembermicrobiome researchorganizational structurepatient derived xenograft modelprogramsprotocol developmentrepositoryresponsesingle cell analysissmall bowel Crohn&aposs diseasesuccesssupport toolstissue processingtranscriptomicsuser-friendly
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY: CLINICAL CORE
The objective of the C-SiG Clinical Core is to provide a user-friendly, one-stop service to access digestive
disease-related biospecimens for Center members. Under the direction of Dr. Lisa Boardman, a well-
established clinician scientist with IRB and biobanking expertise, the organization and infrastructure of the
C-SiG Clinical Core provides essential expertise and personnel to advise and interact with C-SiG members in
pursuit of two Specific Aims: First, to centralize and expedite access to GI biospecimens for C-SiG members.
Second, to enhance existing individual GI-related biobanks operating within the Clinical Core umbrella and
develop new repositories. To achieve these aims C-SiG Clinical Core: i) Integrates existing tissue collections
and annotated data into a collaborative web-based organizational structure that is easily accessible by C-SiG
members; ii) Expedites institutional IRB protocol/biospecimens committee approval and coordinates priority
access for C-SiG members to expert intramural biospecimens processing services; and iii) Facilitates the
initiation of new biobanks that will focus on new diseases or types of biospecimens not currently collected by
existing biobanks, including the development of the new C-SiG Biobank, and iv) Develops and implements
software tools that support digestive disease-related biobank endeavors. The Core integrates existing
resources from individual investigators in the Division of Gastroenterology and Hepatology and from
institutional biospecimens repositories, providing a cost-effective approach to collaboratively translate GI
signaling paradigms into human tissues. Additionally, the C-SiG Clinical Core has developed strong
partnerships with the IRB, anatomic pathology frozen section laboratories (aka TRAG; source of all surgical
biospecimens), and the Pathology Research Core (facility that performs tissue sectioning, immunostaining,
etc.). These partnerships allow C-SiG Clinical Core personnel to expedite movement of protocols and projects
through these key institutional resources. The primary services offered by the C-SiG Clinical Core are IRB
protocol development support, biospecimens request support (including identification of appropriate tissues,
pathology review, & coordinating tissue processing), and biobank support services (IRB protocol templates,
tissue inventory management software, standardized questionnaires, daily searches of the surgical list for
potential biospecimens to be acquired from surgical and/or endoscopy procedures for approved IRB protocols,
and limited study coordinator support for consenting). In response to C-SiG member feedback, we have
recently added services to support the collection of stool for human microbiome research and are developing
an organoid-related service line. The C-SiG Clinical Core services have been used by 54% of the current
Center members and have supported 96 publications in the past 4.5 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Epigenetic mechanisms of carcinogenesis by Parvimonas micra, an oral cavity commensal turned colon cancer pathogen
-
批准号:10693952
-
项目类别:
-
资助金额:$59.39万
-
财政年份:2021
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype
-
批准号:9078116
-
项目类别:
-
资助金额:$63.61万
-
财政年份:2016
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Individualizing colorectal cancer patient care using the host and tumor telomere phenotype
-
批准号:9565504
-
项目类别:
-
资助金额:$65.8万
-
财政年份:2016
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)
-
批准号:8383183
-
项目类别:
-
资助金额:$65.41万
-
财政年份:2012
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)
-
批准号:8917899
-
项目类别:
-
资助金额:$44.55万
-
财政年份:2012
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)
-
批准号:8547044
-
项目类别:
-
资助金额:$60.61万
-
财政年份:2012
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)
-
批准号:8678878
-
项目类别:
-
资助金额:$36.84万
-
财政年份:2012
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Clinical Core
-
批准号:10438742
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2009
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Clinical Core
-
批准号:10630261
-
项目类别:
-
资助金额:$25.1万
-
财政年份:2009
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Telomere length, telomere maintenance genes and cancer risk
-
批准号:8115874
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2008
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Telomere length, telomere maintenance genes and cancer risk
-
批准号:7689319
-
项目类别:
-
资助金额:$56.91万
-
财政年份:2008
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Telomere length, telomere maintenance genes and cancer risk
-
批准号:8287718
-
项目类别:
-
资助金额:$42.51万
-
财政年份:2008
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Telomere length, telomere maintenance genes and cancer risk
-
批准号:7893838
-
项目类别:
-
资助金额:$57.41万
-
财政年份:2008
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Molecular Basis of Young Onset Colorectal Cancer
-
批准号:6889907
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2002
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Molecular Basis of Young Onset Colorectal Cancer
-
批准号:6741829
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2002
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Molecular Basis of Young Onset Colorectal Cancer
-
批准号:6421362
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2002
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Molecular Basis of Young Onset Colorectal Cancer
-
批准号:7061247
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2002
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Molecular Basis of Young Onset Colorectal Cancer
-
批准号:6651078
-
项目类别:
-
资助金额:$12.52万
-
财政年份:2002
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Clinical Core
-
批准号:8737728
-
项目类别:
-
资助金额:$31.63万
-
财政年份:--
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
Clinical Core
-
批准号:9338047
-
项目类别:
-
资助金额:$31.63万
-
财政年份:--
-
负责人:LISA Allyn BOARDMAN
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: